Rocket Lab's Biggest Electron Deal Yet: What It Means for RKLB

Rocket Lab (RKLB) announced on September 30 that Japanese customer Synspective has ordered 20 additional Electron rocket launches, marking the company's largest-ever deal for its small launch vehicle. This brings Synspective's total orders to 47 launches, making it Rocket Lab's biggest customer. The launches are scheduled between 2028 and 2031, averaging about five per year.

While Rocket Lab didn't disclose the financial terms, at the advertised price of $8.4 million per launch, the deal could generate roughly $168 million in revenue. This adds to Rocket Lab's growing backlog, which now exceeds 100 missions, representing over $840 million in future revenue.

This is the fifth major contract win for Rocket Lab in 2026, following several other "biggest-ever" deals earlier in the year, including a $816 million missile defense satellite contract and a $397 million Space Force award. The company has a knack for consistently landing larger and larger deals.

However, the news comes with a caveat: Rocket Lab also announced that the first launch of its much-anticipated Neutron reusable rocket is delayed to 2027. Neutron, with 40 times the payload capacity of Electron, is seen as a key growth driver but won't contribute significantly to revenue for several years.

Despite the delay, Rocket Lab expects to become profitable and free cash flow positive in 2027, partly due to its pending acquisition of Iridium. The Synspective deal reinforces Rocket Lab's leadership in the small launch market and provides a steady stream of future revenue.

The Synspective contract is a strong vote of confidence in Rocket Lab's Electron rocket, which remains the company's workhorse. It demonstrates that demand for small satellite launches is robust and that Rocket Lab is the go-to provider. The deal also deepens the relationship with Synspective, a repeat customer, which could lead to further orders as Synspective expands its satellite constellation.

For investors, the contract adds visibility to future revenue. The $168 million in expected revenue, spread over four years, may seem modest compared to Rocket Lab's total backlog, but it's a high-margin business that helps fund the development of Neutron. Moreover, it shows Rocket Lab's ability to win business even as competition in the launch market intensifies.

The Neutron delay is a setback, as it pushes back the timeline for Rocket Lab to compete directly with SpaceX's Falcon 9 in the medium-lift market. However, the delay is not entirely unexpected given the complexity of developing a new rocket. Investors should focus on the long-term potential: Neutron could significantly expand Rocket Lab's addressable market and improve its economics.

Near-term profitability remains elusive, but the pending Iridium acquisition is expected to accelerate the path to profitability. Once Rocket Lab turns profitable, likely in 2027, the stock could attract a broader investor base and command a higher valuation. For now, the company is investing heavily in growth, and the market is rewarding it for its execution.

Overall, the Synspective deal is a positive development that reinforces Rocket Lab's growth story. It shows that the company can consistently win large contracts and expand its backlog, which is crucial for its long-term success.